Results 11 to 20 of about 269 (119)

Clinical and laboratory characterization of patients with localized scleroderma and response to UVA-1 phototherapy: In vivo and in vitro skin models. [PDF]

open access: yesPhotodermatol Photoimmunol Photomed, 2022
Abstract Background/Purpose Localized scleroderma (LS) is a rare disease leading to progressive hardening and induration of the skin and subcutaneous tissues. LS is responsive to UVA‐1 phototherapy, though its exact mechanism of action dermal fibrosis is yet to be fully elucidated.
Tognetti L   +6 more
europepmc   +5 more sources

UVA-1 phototherapy as adjuvant treatment for eosinophilic fasciitis: in vitro and in vivo functional characterization. [PDF]

open access: yesInt J Dermatol, 2022
Abstract Introduction Eosinophilic fasciitis (EF) is a rare autoimmune disease causing progressive induration of dermal, hypodermal, and muscularis fascia. The exact pathogenesis is yet to be fully understood, and a validated therapy protocol still lacks. We here aimed to realize a clinical–functional characterization of these patients.
Tognetti L   +8 more
europepmc   +5 more sources

Study about evaluation of efficacy of methotrexate in localized scleroderma using ultrasonography. [PDF]

open access: yesSkin Res Technol, 2023
Abstract Background The treatment and curative effect evaluation of localized scleroderma (LS) still perplexes many clinical workers. Purpose To investigate the efficiacy of methotrexate in the treatment of LS by the evaluation of ultrasonography. Methods A prospective study enrolled 10 patients treated with MTX for at least 6 months was conducted ...
Zhang F, Li J, Zhao Q, Liu H, Zhang F.
europepmc   +2 more sources

Connective tissue nevus misdiagnosed as juvenile localized scleroderma. [PDF]

open access: yesPediatr Rheumatol Online J, 2023
BackgroundConnective tissue nevi (CTN) are congenital hamartomas caused by excessive proliferation of dermis components. In children, CTN can mimic juvenile localized scleroderma (JLS), an immune mediated skin disorder that requires aggressive ...
Tirelli F   +7 more
europepmc   +3 more sources

Role of imaging in morphea assessment: A review of the literature. [PDF]

open access: yesSkin Res Technol, 2023
Abstract Background Localized scleroderma, known as morphea, is a connective tissue disorder characterized by inflammation and fibrosis of the skin and the soft tissue. There exist no universally accepted validated outcome measures in order to monitor the disease activity.
Khorasanizadeh F   +2 more
europepmc   +2 more sources

A phase 2b basket trial approach to treat multiple rare and fibrotic skin diseases. [PDF]

open access: yesFront Med (Lausanne)
Fibrotic skin diseases are rare, chronic, and often debilitating conditions characterized by excessive extracellular matrix deposition, leading to tissue scarring and functional impairment.
Volc S   +8 more
europepmc   +3 more sources

КЛІНІЧНІ ОСОБЛИВОСТІ ЛОКАЛІЗОВАНОЇ СКЛЕРОДЕРМІЇ У ПАЦІЄНТІВ ІЗ ЛАЙМ-БОРЕЛІОЗОМ [PDF]

open access: yes, 2022
SUMMARY. The aim – to establish the clinical features of localized scleroderma in patients with Lyme borreliosis. Material and Methods. There were 78 patients with localized scleroderma (LS) aged 18 to 74 years under supervision; in 2015–2021 they were ...
Шкільна, М. І.   +1 more
core   +5 more sources

Pediatric connective tissue diseases:Looking through the skin and beyond [PDF]

open access: yes, 2022
In this thesis new disease biomarkers for chronic autoimmune diseases (‘connective tissue diseases’ (CTD)) such as childhood-onset Systemic Lupus Erythematosus (cSLE), Mixed Connective Tissue Disease (MCTD) and Localized Scleroderma (LS) are discussed ...
Schonenberg-Meinema, D.
core   +4 more sources

Gluten-Free Diet in Children with Dermatologic Pathology

open access: yesПедиатрическая фармакология, 2022
Background. Gluten-free diet (GFD) is a nutritional pattern that excludes such component of grain crops as gluten. This diet administration should be strictly regulated due to its influence on the growing child nutritional status and on the course of ...
Leonid A. Opryatin   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy